Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
![]()
BBS’s mission is to optimise methods and products in bone healing and improve the surgical outcomes in bone substitutes
Share this Article:
Tweet
|
Company
BBS - Bioactive Bone Substitutes
Headquarters
Finland
Management
Ilkka Kangasniemi, CEO
Description
BBS offers a reindeer bone protein extract and the combinations that the firm develops using the extract, which are sold as medical devices. This product is the first of its kind and is safe, efficient, and cost-effective. The company has come a long way with its key product—ARTEBONE—which consists of bone proteins and mineral scaffold and differs greatly from the existing conventional ones. It is a cost-effective offering, used while treating bone defects and healing foot or ankle extremities. In addition to designing and manufacturing bone graft substitutes, this Finnish health technology company also provides unique bioactive implants that offer clinical and financial benefits for patients suffering from bone defects
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info